Phenylephrine Dosing
For intravenous phenylephrine in adults, use 50-250 mcg boluses for perioperative hypotension or 0.5-1.4 mcg/kg/min continuous infusion, titrated to effect; for vasodilatory shock, infuse 0.5-6 mcg/kg/min. 1
Intravenous Administration
Perioperative Hypotension
The FDA-approved dosing for phenylephrine IV is well-established 1:
Bolus dosing: 50-250 mcg IV push
- Initial dose typically 40-100 mcg
- Additional boluses up to 200 mcg may be given every 1-2 minutes as needed 2
- Titrate based on blood pressure response
Continuous infusion: 0.5-1.4 mcg/kg/min
- Start at lower end and titrate upward
- Typical starting dose in a 70 kg adult: 35-140 mcg/min 3
Vasodilatory/Septic Shock
- Continuous infusion: 0.5-6 mcg/kg/min, titrated to maintain adequate blood pressure 1
- Requires continuous hemodynamic monitoring
- Used when severe hypotension (systolic BP <70 mmHg) occurs with low total peripheral resistance 3
Critical Preparation Note
Phenylephrine 10 mg/mL MUST BE DILUTED before administration 1. The ready-to-use 100 mcg/mL formulation does NOT require dilution 2.
Intranasal Administration
Nasal Decongestion
Intranasal phenylephrine is NOT recommended for nasal congestion - recent evidence demonstrates it is ineffective at FDA-approved doses 4, 5. The FDA has proposed removing oral phenylephrine from over-the-counter products due to lack of efficacy 5.
Surgical Use (Vasoconstriction)
When used topically for surgical procedures:
- Concentration: 0.25% solution is preferred over higher concentrations 6
- Volume: Limit application to minimize systemic absorption
- Pediatric caution: Concentrations of 0.5% and 1% have caused severe hypertension and pulmonary edema in children 6, 7
- Ten of 18 surveyed hospitals with large pediatric ENT volumes have abandoned phenylephrine use due to hypertensive complications 6
Oral Administration
Oral phenylephrine is NOT effective for nasal congestion 4, 5. Studies show:
- No statistically significant improvement over placebo at doses up to 40 mg every 4 hours 4
- Poor bioavailability (F = 0.0128) with slow absorption 7
- The FDA has proposed removing it from over-the-counter products 5
Special Populations
Obstetric Patients
For spinal anesthesia-induced hypotension during cesarean delivery:
- Prophylactic infusion: 0.42-0.68 mcg/kg/min (ED50 to ED90) in obese parturients 8
- Bolus treatment: 60 mcg IV for severe preeclampsia 9
- Alternative: Norepinephrine shows comparable efficacy with potential hemodynamic advantages, though phenylephrine remains guideline-supported first-line 10
Pediatric Dosing
- IV for shock: 0.1-2.0 mcg/kg/min continuous infusion 11
- Intranasal for surgery: Use 0.25% concentration maximum; avoid 0.5-1% due to severe hypertension risk 6, 7
Critical Safety Considerations
Extravasation Risk
Phenylephrine causes tissue necrosis if extravasated 3, 11:
- Treatment: Infiltrate phentolamine 0.1-0.2 mg/kg (up to 10 mg) diluted in 10 mL saline into extravasation site immediately 3, 11
- Prefer central line administration when possible 3
Adverse Effects
- Reflex bradycardia: Common, may reduce cardiac output 3
- Hypertension: Especially with topical use in children 6
- Pulmonary edema: Reported when beta-blockers used to treat phenylephrine-induced hypertension 6
Drug Interactions
- Avoid beta-blockers for treating phenylephrine-induced hypertension - use alpha-blockers instead 6
- MAO inhibitors, tricyclic antidepressants, and oxytocic drugs potentiate pressor effects 1, 2
Clinical Pitfall
The most critical error is using phenylephrine orally or intranasally for congestion - it simply does not work 4, 5. For IV use, the second major pitfall is failing to dilute the 10 mg/mL concentration, which can cause severe complications 1.